Search research articles
Contact Us
Filters
Showing results (231-240 of 298) with videos related to
Page
of 30
Sort By:
The Journal of Clinical Investigation
|
September 9, 2025
Statin-dependent and -independent pathways are associated with major adverse cardiovascular events in people with HIV
Márton Kolossváry, Irini Sereti, Markella V Zanni, et al.
The Journal of Infectious Diseases
|
July 22, 2024
SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback
Nathaniel Bloom, Sydney I Ramirez, Hallie Cohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2023
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial
Nikolaus Jilg, Kara W Chew, Mark J Giganti, et al.
Journal of Clinical and Translational Science
|
November 14, 2024
ACTIV trials: cross-trial lessons learned for master protocol implementation
Maryam Keshtkar-Jahromi, Stacey J Adam, Indira Brar, et al.
Open Forum Infectious Diseases
|
April 10, 2025
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort
Emma Davies Smith, Carlos Malvestutto, Heather J Ribaudo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
Anne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
The Lancet. HIV
|
May 1, 2026
Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial
Esteban Martínez, Maya Watanabe, Risa Hoffman, et al.
The Journal of Infectious Diseases
|
May 8, 2024
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2
Manish C Choudhary, Rinki Deo, Teresa H Evering, et al.
The Journal of Infectious Diseases
|
July 10, 2020
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial
Markella V Zanni, Judith S Currier, Amy Kantor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 13, 2023
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort
Borek Foldyna, Thomas Mayrhofer, Markella V Zanni, et al.
Page
of 30
Search research articles
Search
Showing results (231-240 of 298) with videos related to
Sort By:
Page
of 30
The Journal of Clinical Investigation
|
September 9, 2025
Statin-dependent and -independent pathways are associated with major adverse cardiovascular events in people with HIV
Márton Kolossváry, Irini Sereti, Markella V Zanni, et al.
The Journal of Infectious Diseases
|
July 22, 2024
SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback
Nathaniel Bloom, Sydney I Ramirez, Hallie Cohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2023
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial
Nikolaus Jilg, Kara W Chew, Mark J Giganti, et al.
Journal of Clinical and Translational Science
|
November 14, 2024
ACTIV trials: cross-trial lessons learned for master protocol implementation
Maryam Keshtkar-Jahromi, Stacey J Adam, Indira Brar, et al.
Open Forum Infectious Diseases
|
April 10, 2025
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort
Emma Davies Smith, Carlos Malvestutto, Heather J Ribaudo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
Anne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
The Lancet. HIV
|
May 1, 2026
Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial
Esteban Martínez, Maya Watanabe, Risa Hoffman, et al.
The Journal of Infectious Diseases
|
May 8, 2024
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2
Manish C Choudhary, Rinki Deo, Teresa H Evering, et al.
The Journal of Infectious Diseases
|
July 10, 2020
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial
Markella V Zanni, Judith S Currier, Amy Kantor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 13, 2023
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort
Borek Foldyna, Thomas Mayrhofer, Markella V Zanni, et al.
Page
of 30